Great to see where ReIMAGINE started and where we are today with Principal Investigator Prof Mark Emberton

Thank you Caroline Moore .Watch this space for more work from ReIMAGINE. Follow up study with new arm targeting hard to reach populations. Look out for the MRI van👀

Pleased to hear about the work Jo Hadley does with the patients in the background and all the work done during COVID to protect patients at the event this evening

Interesting to hear from site staff Ashling Henderson in her role as a tissue tech and a clinical trial practitioner, both patient facing roles involving the collection of samples

Head of work strand 6 AttardLab shares with us the great news that 99% of samples were collected. Impressive result! All thanks to our most important partner, the patients 👏

Thanks work strand 6 for taking us on a journey from biopsy to the lab, to data analysis and results, and then on to impact

Excited to share all the work done with AttardLab at the ReIMAGINE PPI event today.

Excited to have 1 of our 16 commercial partners Lucida Medical with us this evening sharing the work they are doing using #artificalintelligence to improve patient outcomes

It’s not over yet, introducing ReIMAGINE Life. John Withington tells us more about the next phase of ReIMAGINE where the group of 1000 men from work stand 1 will be followed up for life.

So many interesting people that make up the ReIMAGINE Consortium like Tom Syer who prepares the imaging data for work strand 1, prostate cancer risk study. Watch this space for more information on the AI Challenge.

Great to see how multidisciplinary collaboration works to bring about positive change. Statisticians analysing data & mathematicians developing advanced statistical models with the over arching aim of bringing about personalised medicine

Prof @Shonit outlined the future of MRI with new types of imaging and how this can prevent unnecessary biopsies and over treatment at today’s online event

Many thanks to Prof @MiekeVHR & Rosie Clow who were our hosts for this evening’s final online public engagement event. We appreciate you taking us on a journey of the different work strands and teams that make up the ReIMAGINE Consortium

Talking about the ReIMAGINE stats 📈📊📉 at the final PPI event! #prostatecancer

It was a pleasure to join ReIMAGINE. We're delighted to support this research to change the way we diagnose and treat #ProstateCancer and present our work Lucida Medical to help make diagnosis faster and more accurate.

📢 Are you interested in learning more about #HIFU or #cryotherapy to treat prostate cancer? Ask the experts! 📢 Register for our FREE patient webinar @ imperialprostate.org/support 📅 Wednesday 28 June, 2023 ⏱️ 4:00PM - 5:00PM (BST) #UrSoMe #ProstateCancerSupport #FocalTherapy

Heading to #UROonc23 to explain tomorrow how focal HIFU and focal cryotherapy are standard approaches in managing localised prostate cancer. Eligible men should be informed!

A big THANK YOU to our consensus meeting Chair @JanvanderMeule6 and to everyone who participated in our #NCITA #Consensus Group meeting discussions both in person and virtually to build consensus on accelerating #PET #radiotracer and #MRI biomarkers into clinical practice!

A screening programme for prostate cancer could be on the horizon using MRI - which is far better than blood tests at accurately spotting cancer. But it may take another decade. bbc.co.uk/news/health-66…

New research from UCLH UCL & King's College London has found that #MRI can help detect prostate cancers missed by blood (PSA) tests. Caroline Moore Mark Emberton UCL Div of Surgery UCL Cancer Institute BMJ Oncology uclh.nhs.uk/news/mri-scans…